Selected research
Industry Research
OTC Artificial Tears Industry Research Report 2026
Market perspective
The global OTC Artificial Tears market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for OTC Artificial Tears is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for OTC Artificial Tears is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for OTC Artificial Tears is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of OTC Artificial Tears include Akorn, Inc., Alcon, Bausch and Lamb, OcuSoft, Similasan Corporation, Sun Pharmaceutical Industries Limited, Ursapharm Arzneimittel GmbH, AbbVie, Inc. and Santen Pharmaceutical Co. Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global OTC Artificial Tears market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
OTC Artificial Tears Market by Company
Akorn, Inc.
Alcon
Bausch and Lamb
OcuSoft
Similasan Corporation
Sun Pharmaceutical Industries Limited
Ursapharm Arzneimittel GmbH
AbbVie, Inc.
Santen Pharmaceutical Co. Ltd
Johnson and Johnson
OTC Artificial Tears Segment by Type
Preservative Based
Non-preservative Based
OTC Artificial Tears Segment by Application
Hospital Pharmacies
Drug Stores
Online
OTC Artificial Tears Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Artificial Tears market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of OTC Artificial Tears and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Artificial Tears.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of OTC Artificial Tears manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of OTC Artificial Tears by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of OTC Artificial Tears in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Preservative Based
- Non-preservative Based
Applications
- Hospital Pharmacies
- Drug Stores
- Online
Companies covered
- Akorn, Inc.
- Alcon
- Bausch and Lamb
- OcuSoft
- Similasan Corporation
- Sun Pharmaceutical Industries Limited
- Ursapharm Arzneimittel GmbH
- AbbVie, Inc.
- Santen Pharmaceutical Co. Ltd
- Johnson and Johnson
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global OTC Artificial Tears Market Size (2021-2032)
- 2.2.2 Global OTC Artificial Tears Sales (2021-2032)
- 2.2.3 Global OTC Artificial Tears Market Average Price (2021-2032)
- 2.3 OTC Artificial Tears by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Preservative Based
- 2.3.3 Non-preservative Based
- 2.4 OTC Artificial Tears by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital Pharmacies
- 2.4.3 Drug Stores
- 2.4.4 Online
3 Market Competitive Landscape by Manufacturers
- 3.1 Global OTC Artificial Tears Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global OTC Artificial Tears Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global OTC Artificial Tears Revenue of Manufacturers (2021-2026)
- 3.4 Global OTC Artificial Tears Average Price by Manufacturers (2021-2026)
- 3.5 Global OTC Artificial Tears Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of OTC Artificial Tears, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of OTC Artificial Tears, Product Type & Application
- 3.8 Global Manufacturers of OTC Artificial Tears, Established Date
- 3.9 Global OTC Artificial Tears Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Akorn, Inc.
- 4.1.1 Akorn, Inc. Company Information
- 4.1.2 Akorn, Inc. Business Overview
- 4.1.3 Akorn, Inc. OTC Artificial Tears Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Akorn, Inc. OTC Artificial Tears Product Portfolio
- 4.1.5 Akorn, Inc. Recent Developments
- 4.2 Alcon
- 4.2.1 Alcon Company Information
- 4.2.2 Alcon Business Overview
- 4.2.3 Alcon OTC Artificial Tears Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Alcon OTC Artificial Tears Product Portfolio
- 4.2.5 Alcon Recent Developments
- 4.3 Bausch and Lamb
- 4.3.1 Bausch and Lamb Company Information
- 4.3.2 Bausch and Lamb Business Overview
- 4.3.3 Bausch and Lamb OTC Artificial Tears Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Bausch and Lamb OTC Artificial Tears Product Portfolio
- 4.3.5 Bausch and Lamb Recent Developments
- 4.4 OcuSoft
- 4.4.1 OcuSoft Company Information
- 4.4.2 OcuSoft Business Overview
- 4.4.3 OcuSoft OTC Artificial Tears Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 OcuSoft OTC Artificial Tears Product Portfolio
- 4.4.5 OcuSoft Recent Developments
- 4.5 Similasan Corporation
- 4.5.1 Similasan Corporation Company Information
- 4.5.2 Similasan Corporation Business Overview
- 4.5.3 Similasan Corporation OTC Artificial Tears Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Similasan Corporation OTC Artificial Tears Product Portfolio
- 4.5.5 Similasan Corporation Recent Developments
- 4.6 Sun Pharmaceutical Industries Limited
- 4.6.1 Sun Pharmaceutical Industries Limited Company Information
- 4.6.2 Sun Pharmaceutical Industries Limited Business Overview
- 4.6.3 Sun Pharmaceutical Industries Limited OTC Artificial Tears Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Sun Pharmaceutical Industries Limited OTC Artificial Tears Product Portfolio
- 4.6.5 Sun Pharmaceutical Industries Limited Recent Developments
- 4.7 Ursapharm Arzneimittel GmbH
- 4.7.1 Ursapharm Arzneimittel GmbH Company Information
- 4.7.2 Ursapharm Arzneimittel GmbH Business Overview
- 4.7.3 Ursapharm Arzneimittel GmbH OTC Artificial Tears Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Ursapharm Arzneimittel GmbH OTC Artificial Tears Product Portfolio
- 4.7.5 Ursapharm Arzneimittel GmbH Recent Developments
- 4.8 AbbVie, Inc.
- 4.8.1 AbbVie, Inc. Company Information
- 4.8.2 AbbVie, Inc. Business Overview
- 4.8.3 AbbVie, Inc. OTC Artificial Tears Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 AbbVie, Inc. OTC Artificial Tears Product Portfolio
- 4.8.5 AbbVie, Inc. Recent Developments
- 4.9 Santen Pharmaceutical Co. Ltd
- 4.9.1 Santen Pharmaceutical Co. Ltd Company Information
- 4.9.2 Santen Pharmaceutical Co. Ltd Business Overview
- 4.9.3 Santen Pharmaceutical Co. Ltd OTC Artificial Tears Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Santen Pharmaceutical Co. Ltd OTC Artificial Tears Product Portfolio
- 4.9.5 Santen Pharmaceutical Co. Ltd Recent Developments
- 4.10 Johnson and Johnson
- 4.10.1 Johnson and Johnson Company Information
- 4.10.2 Johnson and Johnson Business Overview
- 4.10.3 Johnson and Johnson OTC Artificial Tears Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Johnson and Johnson OTC Artificial Tears Product Portfolio
- 4.10.5 Johnson and Johnson Recent Developments
5 Global OTC Artificial Tears Market Scenario by Region
- 5.1 Global OTC Artificial Tears Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global OTC Artificial Tears Sales by Region: 2021-2032
- 5.2.1 Global OTC Artificial Tears Sales by Region: 2021-2026
- 5.2.2 Global OTC Artificial Tears Sales by Region: 2027-2032
- 5.3 Global OTC Artificial Tears Revenue by Region: 2021-2032
- 5.3.1 Global OTC Artificial Tears Revenue by Region: 2021-2026
- 5.3.2 Global OTC Artificial Tears Revenue by Region: 2027-2032
- 5.4 North America OTC Artificial Tears Market Facts & Figures by Country
- 5.4.1 North America OTC Artificial Tears Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America OTC Artificial Tears Sales by Country (2021-2032)
- 5.4.3 North America OTC Artificial Tears Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe OTC Artificial Tears Market Facts & Figures by Country
- 5.5.1 Europe OTC Artificial Tears Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe OTC Artificial Tears Sales by Country (2021-2032)
- 5.5.3 Europe OTC Artificial Tears Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific OTC Artificial Tears Market Facts & Figures by Country
- 5.6.1 Asia Pacific OTC Artificial Tears Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific OTC Artificial Tears Sales by Country (2021-2032)
- 5.6.3 Asia Pacific OTC Artificial Tears Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America OTC Artificial Tears Market Facts & Figures by Country
- 5.7.1 South America OTC Artificial Tears Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America OTC Artificial Tears Sales by Country (2021-2032)
- 5.7.3 South America OTC Artificial Tears Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa OTC Artificial Tears Market Facts & Figures by Country
- 5.8.1 Middle East and Africa OTC Artificial Tears Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa OTC Artificial Tears Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa OTC Artificial Tears Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global OTC Artificial Tears Sales by Type (2021-2032)
- 6.1.1 Global OTC Artificial Tears Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global OTC Artificial Tears Sales Market Share by Type (2021-2032)
- 6.2 Global OTC Artificial Tears Revenue by Type (2021-2032)
- 6.2.1 Global OTC Artificial Tears Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global OTC Artificial Tears Revenue Market Share by Type (2021-2032)
- 6.3 Global OTC Artificial Tears Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global OTC Artificial Tears Sales by Application (2021-2032)
- 7.1.1 Global OTC Artificial Tears Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global OTC Artificial Tears Sales Market Share by Application (2021-2032)
- 7.2 Global OTC Artificial Tears Revenue by Application (2021-2032)
- 7.2.1 Global OTC Artificial Tears Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global OTC Artificial Tears Revenue Market Share by Application (2021-2032)
- 7.3 Global OTC Artificial Tears Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 OTC Artificial Tears Value Chain Analysis
- 8.1.1 OTC Artificial Tears Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 OTC Artificial Tears Production Mode & Process
- 8.2 OTC Artificial Tears Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 OTC Artificial Tears Distributors
- 8.2.3 OTC Artificial Tears Customers
9 Global OTC Artificial Tears Analyzing Market Dynamics
- 9.1 OTC Artificial Tears Industry Trends
- 9.2 OTC Artificial Tears Industry Drivers
- 9.3 OTC Artificial Tears Industry Opportunities and Challenges
- 9.4 OTC Artificial Tears Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst